The Advancing Drug Development Forum has confirmed a prestigious line-up of leading industry voices to speak at its inaugural West Coast event ‘Advancing Drug Development Forum – Making the Impossible, Possible’, on June 14, 2018 at the San Francisco Wine School in South San Francisco, CA.
Juniper will be joining key opinion leaders in biotech and pharma to explore novel solutions, promising technology breakthroughs and how the industry introduces and incorporates improved approaches in small molecule drug development. The impressive line-up includes an opening keynote: “From the Front Office – Minimizing CMC Risk to Maximize ROI”, followed by a panel discussion on “Novel Innovative Technologies”. The forum will explore how consultants, CROs and CMOs must invest in their resources to meet the evolving demands of drug development. This includes informed discussion around the current regulatory and FDA Landscape, followed by a panel discussion on selecting and integrating innovative technologies and new approaches to the CDMO world and the challenges of novel drug delivery.”
The afternoon discussion will continue with the “Investment Small Molecule Landscape” Keynote, and Kevin J. Bittorf, VP CMC and BD, Trek Therapeutics presenting on “The Value IOT Brings Developing a Quality Product”. The closing presentation “Why our Compound Failed? Can we Reformulate and Start Over! or Giving Failed Drugs a Fresh Start and a New Direction” will be followed by a Panel Discussion and a Fireside Chat with Faculty and Attendees.
Register online to attend this event and join the debate around improving the process for developing complex drug formulation and manufacturing methods.